vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and WORKIVA INC (WK). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $247.3M, roughly 1.4× WORKIVA INC). WORKIVA INC runs the higher net margin — 7.7% vs 4.0%, a 3.7% gap on every dollar of revenue. On growth, WORKIVA INC posted the faster year-over-year revenue change (19.9% vs 2.2%).
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Workiva, Inc. is a global software-as-a-service (SaaS) company. It provides a cloud-based connected and reporting compliance platform that enables the use of connected data and automation of reporting across finance, accounting, risk, and compliance.
GRDN vs WK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $336.6M | $247.3M |
| Net Profit | $13.5M | $19.0M |
| Gross Margin | 22.7% | 80.4% |
| Operating Margin | 5.3% | 25.8% |
| Net Margin | 4.0% | 7.7% |
| Revenue YoY | 2.2% | 19.9% |
| Net Profit YoY | 46.1% | — |
| EPS (diluted) | $0.21 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.6M | $247.3M | ||
| Q4 25 | $397.6M | $238.9M | ||
| Q3 25 | $377.4M | $224.2M | ||
| Q2 25 | $344.3M | $215.2M | ||
| Q1 25 | $329.3M | $206.3M | ||
| Q4 24 | — | $199.9M | ||
| Q3 24 | $314.4M | $185.6M | ||
| Q2 24 | — | $177.5M |
| Q1 26 | $13.5M | $19.0M | ||
| Q4 25 | $20.9M | $11.8M | ||
| Q3 25 | $9.8M | $2.8M | ||
| Q2 25 | $9.0M | $-19.4M | ||
| Q1 25 | $9.4M | $-21.4M | ||
| Q4 24 | — | $-8.8M | ||
| Q3 24 | $-122.0M | $-17.0M | ||
| Q2 24 | — | $-17.5M |
| Q1 26 | 22.7% | 80.4% | ||
| Q4 25 | 21.5% | 80.7% | ||
| Q3 25 | 19.8% | 79.3% | ||
| Q2 25 | 19.8% | 77.0% | ||
| Q1 25 | 19.5% | 76.6% | ||
| Q4 24 | — | 77.1% | ||
| Q3 24 | 19.4% | 76.5% | ||
| Q2 24 | — | 76.8% |
| Q1 26 | 5.3% | 25.8% | ||
| Q4 25 | 7.7% | 3.3% | ||
| Q3 25 | 4.3% | -1.5% | ||
| Q2 25 | 3.7% | -10.3% | ||
| Q1 25 | 3.9% | -12.0% | ||
| Q4 24 | — | -6.7% | ||
| Q3 24 | -33.3% | -11.7% | ||
| Q2 24 | — | -13.0% |
| Q1 26 | 4.0% | 7.7% | ||
| Q4 25 | 5.3% | 4.9% | ||
| Q3 25 | 2.6% | 1.2% | ||
| Q2 25 | 2.6% | -9.0% | ||
| Q1 25 | 2.9% | -10.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | -38.8% | -9.2% | ||
| Q2 24 | — | -9.9% |
| Q1 26 | $0.21 | $0.33 | ||
| Q4 25 | — | $0.21 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $-0.35 | ||
| Q1 25 | — | $-0.38 | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.9M | $334.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $232.4M | — |
| Total Assets | $426.9M | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $64.9M | $334.3M | ||
| Q4 25 | $65.6M | $338.8M | ||
| Q3 25 | $36.5M | $315.9M | ||
| Q2 25 | $18.8M | $284.3M | ||
| Q1 25 | $14.0M | $242.0M | ||
| Q4 24 | — | $301.8M | ||
| Q3 24 | $37.2M | $248.2M | ||
| Q2 24 | — | $267.9M |
| Q1 26 | — | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — |
| Q1 26 | $232.4M | — | ||
| Q4 25 | $217.9M | $-5.4M | ||
| Q3 25 | $195.5M | $-36.9M | ||
| Q2 25 | $179.7M | $-66.5M | ||
| Q1 25 | $163.2M | $-75.7M | ||
| Q4 24 | — | $-41.7M | ||
| Q3 24 | $133.9M | $-50.8M | ||
| Q2 24 | — | $-77.7M |
| Q1 26 | $426.9M | $1.4B | ||
| Q4 25 | $412.7M | $1.5B | ||
| Q3 25 | $390.0M | $1.4B | ||
| Q2 25 | $356.3M | $1.3B | ||
| Q1 25 | $334.0M | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $348.0M | $1.3B | ||
| Q2 24 | — | $1.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.1M | — |
| Free Cash FlowOCF − Capex | — | $25.7M |
| FCF MarginFCF / Revenue | — | 10.4% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.45× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $171.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $6.1M | — | ||
| Q4 25 | $34.6M | $51.0M | ||
| Q3 25 | $28.2M | $46.2M | ||
| Q2 25 | $19.9M | $50.3M | ||
| Q1 25 | $17.6M | $-7.4M | ||
| Q4 24 | — | $44.0M | ||
| Q3 24 | — | $18.9M | ||
| Q2 24 | — | $-14.0K |
| Q1 26 | — | $25.7M | ||
| Q4 25 | — | $50.7M | ||
| Q3 25 | $24.2M | $46.1M | ||
| Q2 25 | — | $49.3M | ||
| Q1 25 | — | $-8.1M | ||
| Q4 24 | — | $43.2M | ||
| Q3 24 | — | $18.7M | ||
| Q2 24 | — | $-122.0K |
| Q1 26 | — | 10.4% | ||
| Q4 25 | — | 21.2% | ||
| Q3 25 | 6.4% | 20.5% | ||
| Q2 25 | — | 22.9% | ||
| Q1 25 | — | -3.9% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | — | 10.1% | ||
| Q2 24 | — | -0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | 1.1% | 0.0% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% |
| Q1 26 | 0.45× | — | ||
| Q4 25 | 1.65× | 4.31× | ||
| Q3 25 | 2.87× | 16.57× | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
WK
| Subscription and support | $225.4M | 91% |
| Other | $22.0M | 9% |
